Telemedicine-Delivered Cognitive Behavioral Therapy + CGM for Type 1 Diabetes & Mental Health
(UP-CBT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests if using mental health support along with a blood sugar monitoring device helps adults with type 1 diabetes manage their condition better. The study focuses on those who struggle with both mental health and blood sugar control.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications, but you must be on a stable dose of any psychotropic medication for at least 6 weeks before joining.
Is the Unified Protocol for Cognitive Behavioral Therapy safe for humans?
How is the treatment Unified Protocol for Cognitive Behavioral Therapy (UP-CBT) unique for type 1 diabetes and mental health?
The Unified Protocol for Cognitive Behavioral Therapy (UP-CBT) is unique because it is a flexible therapy that can be delivered via telemedicine and targets a wide range of emotional disorders, making it adaptable for individuals with type 1 diabetes who may also experience mental health challenges. This approach combines cognitive behavioral therapy with continuous glucose monitoring (CGM) to address both psychological and diabetes management needs.13678
What data supports the effectiveness of the treatment Telemedicine-Delivered Cognitive Behavioral Therapy + CGM for Type 1 Diabetes & Mental Health?
Research shows that the Unified Protocol (UP), a flexible form of cognitive behavioral therapy, is effective for treating various emotional disorders, including anxiety and mood disorders, when delivered virtually. This suggests that UP could be beneficial for mental health in people with Type 1 Diabetes when combined with continuous glucose monitoring.12345
Who Is on the Research Team?
Jeffrey Gonzalez, PhD
Principal Investigator
Albert Einstein College of Medicine
Are You a Good Fit for This Trial?
This trial is for English or Spanish-speaking young adults aged 18-35 with Type 1 diabetes and HbA1c levels between 7.5% and 14%. Participants must have had diabetes for at least six months and be diagnosed with anxiety or depression. It's not open to those with certain disabilities, pregnant women, recent users of psychotropic medications without a stable dose, or individuals who've recently used CBT.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Unified Protocol for Cognitive Behavioral Therapy (UP-CBT) with Continuous Glucose Monitoring (CGM) or CGM only for the first 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of anxiety, depression, and glycemic control
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Glucose Monitoring (CGM)
- Unified Protocol for Cognitive Behavioral Therapy (UP-CBT)
Unified Protocol for Cognitive Behavioral Therapy (UP-CBT) is already approved in United States, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein College of Medicine
Lead Sponsor
Juvenile Diabetes Research Foundation
Collaborator
DexCom, Inc.
Industry Sponsor
Kevin Sayer
DexCom, Inc.
Chief Executive Officer since 2015
Bachelorโs and Masterโs degrees in Accounting and Information Systems from Brigham Young University
Dr. Shelly Lane
DexCom, Inc.
Chief Medical Officer since 2023
MD from University of California, San Diego